Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
Michael A. Carducci
ResearcherPublications, citations & collaboration network
Michael A. Carducci is a researcher indexed in ScholarIQ from OpenAlex & ORCID. ScholarIQ records 1,049 works, 55,554 citations, an h-index of 104 and an i10-index of 402.
1,049
Works
55,554
Citations
104
h-index
402
i10-index
How has Michael A. Carducci's publication output changed over time?
ScholarIQpublication output · 1999–2020
Output grew0% over the shown period — from 1 works in 1999 to 1 in 2020.
1
1
1
1
1
2
1
2
1
1
1999200720082009201120142015201620182020
What are the most-cited papers on Michael A. Carducci?
ScholarIQmost cited works
Temsirolimus, Interferon Alfa, or Both for Advanced Renal-Cell Carcinoma
Gary R. Hudes, Michael A. Carducci, Piotr Tomczak, Janice Dutcher, Robert A. Figlin, Anil Kapoor, Elżbieta Starosławska, Jeffrey A. Sosman, David McDermott, I. Bodrogi, Zoran Kovačević, Vladimir Lesovoy, Ingo G.H. Schmidt‐Wolf, О. Л. Барбараш, Erhan Gökmen, Timothy E. O’Toole, Stephanie Lustgarten, Laurence Moore, Robert J. Motzer
New England Journal of Medicine. 20073,653 Citations
Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer
Christopher J. Sweeney, Yu‐Hui Chen, Michael A. Carducci, Glenn Liu, David F. Jarrard, Mario A. Eisenberger, Yu-Ning Wong, Noah M. Hahn, Manish Kohli, Matthew M. Cooney, Robert Dreicer, Nicholas J. Vogelzang, Joel Picus, Daniel H. Shevrin, Maha Hussain, Jorge A. García, Robert S. DiPaola
New England Journal of Medicine. 20152,869 CitationsOPEN ACCESS
AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate Cancer
Emmanuel S. Antonarakis, Changxue Lu, Hao Wang, Brandon Luber, Mari Nakazawa, Jeffrey C. Roeser, Yan Chen, Tabrez A. Mohammad, Yidong Chen, Helen Fedor, Tamara L. Lotan, Qizhi Zheng, Angelo M. De Marzo, John T. Isaacs, William B. Isaacs, Rosa Nadal, Channing J. Paller, Samuel R. Denmeade, Michael A. Carducci, Mario A. Eisenberger, Jun Luo
New England Journal of Medicine. 20142,714 CitationsOPEN ACCESS
Design and End Points of Clinical Trials for Patients With Progressive Prostate Cancer and Castrate Levels of Testosterone: Recommendations of the Prostate Cancer Clinical Trials Working Group
Howard I. Scher, Susan Halabi, Ian F. Tannock, Michael J. Morris, Cora N. Sternberg, Michael A. Carducci, Mario A. Eisenberger, Celestia S. Higano, Glenn J. Bubley, Robert Dreicer, Daniel Petrylak, Philip W. Kantoff, Ethan Basch, William Kevin Kelly, William D. Figg, Eric J. Small, Tomasz M. Beer, George Wilding, Alison Martin, Maha Hussain
Journal of Clinical Oncology. 20082,255 CitationsOPEN ACCESS
Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial
Roland R. Griffiths, Matthew W. Johnson, Michael A. Carducci, Annie Umbricht, William A. Richards, Brian D. Richards, Mary P Cosimano, Margaret A. Klinedinst
Journal of Psychopharmacology. 20162,197 CitationsOPEN ACCESS
Related on ScholarIQ
Johns Hopkins University
Institution
Temsirolimus, Interferon Alfa, or Both for Advanced Renal-Cell Carcinoma
Paper
Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer
Paper
AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate Cancer
Paper
Design and End Points of Clinical Trials for Patients With Progressive Prostate Cancer and Castrate Levels of Testosterone: Recommendations of the Prostate Cancer Clinical Trials Working Group
Paper
Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial
Paper